These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 17958509)

  • 21. Probabilistic risk analysis is practical.
    Alemi F
    Qual Manag Health Care; 2007; 16(4):300-10. PubMed ID: 18049383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulatory models and the environment: practice, pitfalls, and prospects.
    Holmes KJ; Graham JA; McKone T; Whipple C
    Risk Anal; 2009 Feb; 29(2):159-70. PubMed ID: 19144069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modeling the value for money of changing clinical practice change: a stochastic application in diabetes care.
    Hoomans T; Abrams KR; Ament AJ; Evers SM; Severens JL
    Med Care; 2009 Oct; 47(10):1053-61. PubMed ID: 19648827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding organizational safety using value-focused thinking.
    Merrick JR; Grabowski M; Ayyalasomayajula P; Harrald JR
    Risk Anal; 2005 Aug; 25(4):1029-41. PubMed ID: 16268947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A primer on use of decision analysis methodology in hand surgery.
    Chen NC; Shauver MJ; Chung KC
    J Hand Surg Am; 2009; 34(6):983-90. PubMed ID: 19481363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ranking the risks from multiple hazards in a small community.
    Li H; Apostolakis GE; Gifun J; VanSchalkwyk W; Leite S; Barber D
    Risk Anal; 2009 Mar; 29(3):438-56. PubMed ID: 19076325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An introduction to decision analysis in the economic evaluation of the prevention and treatment of vision-related diseases.
    Kymes SM
    Ophthalmic Epidemiol; 2008; 15(2):76-83. PubMed ID: 18432490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presenting health risk information in different formats: the effect on participants' cognitive and emotional evaluation and decisions.
    Timmermans DR; Ockhuysen-Vermey CF; Henneman L
    Patient Educ Couns; 2008 Dec; 73(3):443-7. PubMed ID: 18722073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicentered study of model of anesthesia related adverse events in Thailand by incident report (The Thai Anesthesia Incidents Monitoring Study): results.
    Charuluxananan S; Suraseranivongse S; Jantorn P; Sriraj W; Chanchayanon T; Tanudsintum S; Kusumaphanyo C; Suratsunya T; Poajanasupawun S; Klanarong S; Pulnitiporn A; Akavipat P; Punjasawadwong Y
    J Med Assoc Thai; 2008 Jul; 91(7):1011-9. PubMed ID: 18839839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update of potency factors for asbestos-related lung cancer and mesothelioma.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patients' responsiveness to a decision support tool for primary prevention of cardiovascular diseases in primary care.
    van Steenkiste B; van der Weijden TM; Stoffers JH; GROL RP
    Patient Educ Couns; 2008 Jul; 72(1):63-70. PubMed ID: 18395393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Human ecology and interdisciplinary cooperation for primary prevention of environmental risk factors for public health].
    Dobrowolski JW
    Przegl Lek; 2007; 64 Suppl 4():35-41. PubMed ID: 18540323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do we know how to set decision thresholds for diabetes?
    Ben-Haim Y; Zacksenhouse M; Keren C; Dacso CC
    Med Hypotheses; 2009 Aug; 73(2):189-93. PubMed ID: 19349125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A decision framework for coordinating bioterrorism planning: lessons from the BioNet program.
    Manley DK; Bravata DM
    Am J Disaster Med; 2009; 4(1):49-57. PubMed ID: 19378669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk analysis for critical asset protection.
    McGill WL; Ayyub BM; Kaminskiy M
    Risk Anal; 2007 Oct; 27(5):1265-81. PubMed ID: 18076495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Taxonometric applications in radiotherapy incident analysis.
    Dunscombe PB; Ekaette EU; Lee RC; Cooke DL
    Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S200-3. PubMed ID: 18406929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic models with competing risks: methods and application to coronary risk prediction.
    Wolbers M; Koller MT; Witteman JC; Steyerberg EW
    Epidemiology; 2009 Jul; 20(4):555-61. PubMed ID: 19367167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.